Generic 180-Day Exclusivity Forfeiture: What If “Failure” Is Not Your Fault?

A generic drug firm at risk of losing 180-day exclusivity for a product because of FDA's new forfeiture triggers may have some legal remedies beyond those already tried against the agency

More from Archive

More from Pink Sheet